SECTOR
Kopran concludes EU GMP inspection of Khopoli facility
Oct-22-2026

Medicine Authority European Union (EU) has conducted GMP inspection at Kopran’s Formulation, manufacturing facility located at Khopoli, Maharashtra. The inspection was conducted from September 18, 2026 to September 23, 2026. The inspection was successfully concluded with No critical observations, one major observation and some minor observations and there were no data integrity related observations.

Kopran is engaged primarily in pharmaceuticals business. The company manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.

  RELATED NEWS >>